Indiana University School of Medicine researcher Jeff Dage’s years of research into biomarkers helped lead to a ...

The approval of Lenacapavir – a twice-yearly antiviral HIV-preventing medication marketed under the brand name Yeztugo – by the US Food and Drug Administration (FDA), has been welcomed by the global ...